December 16, 2011 — Positron Corp. announced this week that on Dec. 12, 2011, its Attrius & Attrius L positron emission tomography (PET) scanners received approval for sale in Canada.
The Medical Device License from Health Canada was granted to the Attrius systems manufacturer, Neusoft Positron Medical Systems. NPMS is a joint venture between Neusoft Medical Systems of Shenyang, China and Positron; Positron has exclusive rights to sell Attrius in North America.
For more information: www.positron.com
June 18, 2024 
![Phase III clinical trial of [18F]flurpiridaz PET diagnostic radiopharmaceutical meets co-primary endpoints for detecting Coronary Artery Disease (CAD)](/sites/default/files/styles/content_feed_medium/public/Screen%20Shot%202022-09-13%20at%203.30.13%20PM.png?itok=2w6OoNd6)
